Skip to content

Janusz Rybakowski

6 papers in the library · 44 citations · publishing 2016-2025

Papers

Sort Most recent Most cited

Mindfulness-Based Art Therapy with Hospitalized Depressed Individuals–The Temporal Order of Change in Mindfulness, Rumination, and Affect

Journal of Happiness Studies August 1, 2025 Maja Stańko-kaczmarek, Tomasz Jankowski, Robert Bartel et al.

Abstract Mindfulness-based art therapy (MBAT) is an interdisciplinary intervention that integrates mindfulness techniques with art activities. While previous research has examined MBAT’s effectiveness in reducing depressive symptoms, little is known about the temporal dynamics of change during participation. This study explored session-to-session changes in mindfulness, rumination, and affect...

Polish standard of treatment with racemic ketamine for patients with depressive disorders developed by a Working Group appointed by the National Consultant in the field of psychiatry.

Psychiatria Polska June 30, 2024 Piotr Gałecki, Katarzyna Maria Bliźniewska-Kowalska, Wiesław Jerzy Cubała et al. 5 citations

The Polish standard of treatment with racemic ketamine for patients with depressive disorders was developed by a Working Group appointed by the National Consultant in the field of psychiatry. Despite the wide range of available medications, as many as one-third of depressed patients do not respond to standard antidepressant treatment, raising the need for an ongoing search for new effective and...

The evolutionary and neurobiological attributes of consciousness: an update.

Psychiatria Polska June 30, 2024 Janusz Rybakowski, Filip Rybakowski

Consciousness is most frequently defined as a subjective experience of mental processes. The phenomenon of consciousness has always been a subject of great interest in various fields of science, including psychiatry, and the most prominent scientists have engaged in research on it. The studies performed in recent years have brought about novel data on the evolutionary and neurobiological...

DOI: 10.12740/PP/174391 (opens in new tab) Full text (opens in new tab) Evolution of consciousness Neurobiology of consciousness

Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression.

International Journal of Psychiatry in Clinical Practice June 2017 Janusz Rybakowski, Agnieszka Permoda‐osip, Alicja Bartkowska-Sniatkowska

To study the clinical effect of a single ketamine infusion, 0.5 mg/kg body weight, in bipolar depressive patients receiving mood-stabilising drugs, not improving on antidepressants. Previously, in such patients, we had found a correlation between clinical efficacy, serum brain-derived neurotrophic factor and vitamin B12 levels and a rapid improvement in neurocognitive performance. The study...

Administration of ketamine for unipolar and bipolar depression.

International Journal of Psychiatry in Clinical Practice March 2017 Christoph Kraus, Ulrich Rabl, Thomas Vanicek et al.

Clinical trials demonstrated that ketamine exhibits rapid antidepressant efficacy when administered in subanaesthetic dosages. We reviewed currently available literature investigating efficacy, response rates and safety profile. Twelve studies investigating unipolar, seven on bipolar depression were included after search in medline, scopus and web of science. Randomized, placebo-controlled or...

Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression

The Journal of ECT September 1, 2016 Janusz Rybakowski, Anna Bodnar, Milosz Krzywotulski et al. 39 citations

Objectives Electroconvulsive therapy (ECT) is the most effective treatment for drug-resistant depression (DRD). Because a single infusion of ketamine may exert both a rapid antidepressant effect and a quick improvement of cognition, the aim of the present study was to assess whether ketamine, as an anesthetic drug for ECT, can augment the antidepressant activity of the procedure and/or exert a...